Additional outcome measures that will help characterize the severity of AMD disease include the following. In the visual field test, the loss of vision occurring predominantly in the central retina, will be quantified. The choroidal and retinal vasculature will be analyzed using fluorescein angiograms, which should reveal abnormal blood vessels and leakage in subjects with systemic vascular problems.